Joerg Zimmermann
Vetter Pharma-Fertigung GmbH & Co., Vice President, Vetter Development Service, External Affairs
Jörg Zimmermann is currently Vice President External Affairs for Vetter Pharma Fertigung GmbH&Co KG, Ravensburg, Germany. In this role, he manages the relationships with regulatory agencies, professional organizations and other partners in the pharmaceutical industry. Before taking this role, he was responsible for Vetter Development Service which includes manufacturing science & process development, technology & process transfers, project & service analytics and drug delivery systems. Within Vetter, Jörg has held various positions in process implementation, new product introduction, lyophilization process development and as production manager before becoming Director of Production of Vetter's production site at Lake Constance in 2000. There he managed 5 production lines for aseptically prefilled injection systems. In September 2010 he became responsible for the process development and process introduction group at Vetter before being promoted to Vice President in November 2014.
Jörg has volunteered as conference chair, track leader and speaker at conferences by ISPE, PDA, and Concept Heidelberg for over 20 years. In 2016, Jörg was elected to the International Board of Directors of ISPE. His current role is Vice Chair to the International Board of Directors and member of the Executive Committee. Jörg studied pharmacy in Freiburg, Germany and Cardiff, Wales and is a registered pharmacist."
Appearances
DateMarch 14, 2022Opening PlenarySpeakers
Vetter Pharma-Fertigung GmbH & Co., Vice President, Vetter Development Service, External AffairsPresident and CEO, ISPE2022-2023 PIC/S Chair, Sr. Corporate Regulatory Compliance & Enforcement Advisor, Regulatory Operations and Enforcement Branch (ROEB), Health CanadaSr. Regulatory Compliance Consultant, Higgins Pharma Consulting GroupDirector, Office of Pharmaceutical Quality Operations, FDA/ORA
DateMarch 14, 2022Design & Development of Components in Aseptic Manufacturing|In this session, two critical types of materials for aseptic processing are covered: pre-sterilized components (syringes, vials, stoppers, etc.) and single-use components (filters, tubing, assemblies)…Speakers
Vetter Pharma-Fertigung GmbH & Co., Vice President, Vetter Development Service, External AffairsStrategic Investment Program Director, Bayer AGKara Vogt, PhDProcess Engineer, Technical Services, INCOG BioPharma ServicesDirector, Technical Services, INCOG Biopharma Services
DateMarch 15, 2022Sterility Assurance practices will need to pivot with a focus on the Microbiological Quality of future products. This means that the sterility assurance community may need to think differently with new innovative products and how we deliver microbiological quality…Speakers
Vetter Pharma-Fertigung GmbH & Co., Vice President, Vetter Development Service, External AffairsVice President of J&J Microbiological Quality and Sterility Assurance, Johnson & Johnson
DateMarch 15, 2022Interactive Regulatory Panel | This is your opportunity to pose your most pressing quality and regulatory questions directly to a panel of respected FDA thought leaders in the aseptic processing space…Speakers
Sr. Regulatory Compliance Consultant, Higgins Pharma Consulting GroupDirector, Office of Pharmaceutical Quality Operations, FDA/ORA2022-2023 PIC/S Chair, Sr. Corporate Regulatory Compliance & Enforcement Advisor, Regulatory Operations and Enforcement Branch (ROEB), Health CanadaVetter Pharma-Fertigung GmbH & Co., Vice President, Vetter Development Service, External AffairsConsumer Safety Officer, FDA/ORA
DateMarch 7, 2023This is your opportunity to pose your most pressing quality and regulatory questions directly to a panel of respected FDA thought leaders in the aseptic processing space…Session Leader
Vetter Pharma-Fertigung GmbH & Co., Vice President, Vetter Development Service, External AffairsSpeakers
Consumer Safety Officer, FDA/CBERDrug National Expert, FDA/ORA
